Literature DB >> 17439931

Capillaroscopy is a dynamic process in mixed connective tissue disease.

A de Holanda Mafaldo Diógenes1, E Bonfá, R Fuller, M T Correia Caleiro.   

Abstract

To determine the clinical relevance of 'scleroderma-pattern' (SD-pattern) in mixed connective tissue disease (MCTD), 63 (MCTD) patients (Kasukawa's criteria) were consecutively selected. The main inclusion criterion was availability of previous nailfold capillaroscopy (NC) five years before inclusion. At entry, organ involvement and autoantibody evaluation were performed. The mean age and disease duration were 45.3 +/- 10 and 8.45 +/- 5.42 years, respectively. SD-pattern was observed in 41 patients at entry (65%) and in 45 at previous NC (71.5%), P = 0.20. Ten patients (16%) changed NC, seven normalized, and three developed SD-pattern. Disease duration, number and frequency of organ involvement were similar in patients with and without SD-pattern. In contrast, analysis of each SD-pattern parameter revealed a significantly lower frequency of moderate/severe avascular areas (AA) at entry compared to previous examination (26.5 versus 53%, P = 0.013). Moreover, 76% of patients with interstitial lung disease (HRCT) had AA at entry, whereas only 24% of patients with this alteration did not have this NC finding (P = 0.017). Furthermore, reduced capillary density was more frequently observed in patients taking immunosuppressive therapy than in those without this medication (66.7 versus 33.3%, P = 0.001). NC in MCTD is a dynamic process and analysis of each SD-pattern parameter seems to be a good indicator of lung involvement and disease severity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17439931     DOI: 10.1177/0961203307076517

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

1.  Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic.

Authors:  Vera Bernardino; Ana Rodrigues; Ana Lladó; António Panarra
Journal:  Rheumatol Int       Date:  2019-08-26       Impact factor: 2.631

Review 2.  Nailfold capillaroscopy in systemic sclerosis - state of the art: The evolving knowledge about capillaroscopic abnormalities in systemic sclerosis.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  J Scleroderma Relat Disord       Date:  2019-04-15

Review 3.  The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2009-06-23       Impact factor: 2.631

Review 4.  Microvascular damage - a marker of specific organ involvement in mixed connective tissue disease?

Authors:  Sylwia Ornowska; Marek Chojnowski; Anna Felis-Giemza; Łukasz Dudek; Marzena Olesińska
Journal:  Reumatologia       Date:  2021-04-27

5.  Capillaroscopy as a diagnostic tool in the diagnosis of mixed connective tissue disease (MCTD): a case report.

Authors:  Mislav Radić; Rebecca S Overbury
Journal:  BMC Rheumatol       Date:  2021-03-19

Review 6.  Capillaroscopy - a role in modern rheumatology.

Authors:  Marek M Chojnowski; Anna Felis-Giemza; Marzena Olesińska
Journal:  Reumatologia       Date:  2016-06-03

7.  Nailfold Videocapillaroscopy in Connective Tissue Diseases with Raynaud's Phenomenon in an Indian Population.

Authors:  Sambit Sundaray; Siddhartha Mishra; Subhash Chandra Dash; Naba Kishore Sundaray
Journal:  Rambam Maimonides Med J       Date:  2022-01-27

8.  Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud's phenomenon.

Authors:  Claudette A Farenhorst; Anniek M Roon; Anne I Gessel; Alja J Stel; Hendrika Bootsma; Wineke Armbrust; Douwe J Mulder
Journal:  Pediatr Rheumatol Online J       Date:  2022-02-08       Impact factor: 3.054

9.  Associations between nailfold capillaroscopy findings and interstitial lung disease in patients with mixed connective tissue disease.

Authors:  Magdalena Celińska-Löwenhoff; Maciej Pastuszczak; Karolina Pełka; Magdalena Stec-Polak; Anna Wojas-Pelc; Jacek Musiał
Journal:  Arch Med Sci       Date:  2019-01-11       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.